U.S.Vaccine Market
U.S. vaccines market is estimated to account for US$ 19,355.2 Mn in terms of value in 2020 and is estimated to account for US$ 27,947.4 Mn by the end of 2027.
U.S. Vaccine Market
2
• A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. Inactivated, attenuated, toxoid, subunit, conjugate, heterotypic, experimental, and valence are the types of vaccines. • Emergence of Covid-19 is expected to propel growth of the U.S. vaccines market over the forecast period. For instance, in the U.S. from January 20, 2020 to 6:01 pm CEST, 6 July 2020, there have been 2,833,552 confirmed cases of COVID-19 with 129,408 deaths, as reported to the World Health Organization • Moreover, R&D initiatives for new vaccines is also expected to aid in growth of the market. For instance, in March 2020, IQVIA and Quest Diagnostics, through its joint venture Q2 Solutions, collaborated with the University of Texas Medical Branch to develop a novel assay for COVID-19 tests for rapid development of a Coronavirus vaccine. U.S. Vaccine Market
3
• By Product Type:
• Human Vaccine: Pediatric Vaccines, Adult & Adolescent Vaccines, Other Human Vaccines. • Animal Vaccine: Livestock Vaccines, Companion Animal Vaccines, Other Animal Vaccines. • By End User: Hospitals, Clinics, Vaccination Centers.
U.S. Vaccine Market
For more details, visithttps://cmiblogdailydose.blogspot.com/20 22/07/us-vaccine-it-is-used-to-protectpeople.html 4
THANK YOU!